Abstract:Patients with ulcerative colitis (UC) have a high prevalence of mental disorders, such as depression and anxiety. Gut microbiota imbalance and disturbed metabolism have been suggested to play an important role in either UC or mental disorders. However, little is known about their detailed multi-omics characteristics in patients with UC and depression/anxiety. In this prospective observational study, 240 Chinese patients were enrolled, including 129 patients with active UC (69 in Phase 1 and 60 in Phase 2; divided into depression/non-depression or anxiety/non-anxiety groups), 49 patients with depression and anxiety (non-UC), and 62 healthy people. The gut microbiota of all subjects was analyzed using 16S rRNA sequencing. The serum metabolome and proteome of patients with UC in Phase 2 were analyzed using liquid chromatography/mass spectrometry. Associations between multi-omics were evaluated by correlation analysis. The prophylactic effect of candidate metabolites on the depressive-like behavior of mice with colitis was investigated. In total, 58% of patients with active UC had depression, while 50% had anxiety. Compared to patients with UC without depression/anxiety, patients with UC and depression/anxiety had lower fecal microbial community richness and diversity, with more Lactobacillales, Sellimonas, Streptococcus, and Enterococcus but less Prevotella_9 and Lachnospira. Most metabolites (e.g., glycochenodeoxycholate) were increased in the serum, while few metabolites, including 2'-deoxy-D-ribose and L-pipecolic acid, were decreased, accompanied by a general reduction in immunoglobulin proteins. These related bacteria, metabolites, and proteins were highly connected. A prophylactic administration of 2'-deoxy-D-ribose and L-pipecolic acid significantly reduced the depressive-like behaviors in mice with colitis and alleviated the inflammatory cytokine levels in their colon, blood and brain. This study has identified a comprehensive multi-omics network related to depression and anxiety in active UC. It is composed of a certain set of gut microbiota, metabolites, and proteins, which are potential targets for clinical intervention for patients with UC and depression/anxiety.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the pathogenesis of depression and anxiety in patients with active ulcerative colitis (UC). Specifically, researchers are concerned about how the interactions among the gut microbiota, metabolomics and proteomics affect the depressive and anxious symptoms of UC patients. By integrating data from these three levels, the study aims to reveal the multi - omics characteristics of depression and anxiety related to UC and explore possible clinical intervention targets. ### Main research questions: 1. **High incidence of depression and anxiety in UC patients**: The study points out that the incidence of depression and anxiety in UC patients is relatively high, which may be due to the chronic course of UC and its negative impact on daily life. 2. **Association among gut microbiota, metabolomics and proteomics**: Researchers hope to find the relationships between these factors and depression and anxiety by analyzing the gut microbiota, serum metabolites and proteins in UC patients. 3. **Potential treatment targets**: Through multi - omics analysis, researchers hope to identify key microorganisms, metabolites and proteins related to depression and anxiety associated with UC, thus providing new ideas for clinical intervention. ### Research methods: - **Cohort study**: The study included 240 Chinese participants, including 129 patients with active UC (divided into depressed/non - depressed or anxious/non - anxious groups), 49 patients with depression and anxiety without UC and 62 healthy control groups. - **Microbiome analysis**: 16S rRNA sequencing was used to analyze the gut microbiota of all participants. - **Metabolomics analysis**: Liquid chromatography - mass spectrometry was used to analyze the serum metabolome of UC patients in the second stage. - **Proteomics analysis**: Tandem mass tag reagents were used to analyze the serum proteome of UC patients. - **Animal experiments**: By orally administering specific metabolites to mice, the effects of these metabolites on depressive - like and anxious - like behaviors in colitis mice were evaluated. ### Main findings: - **Depression and anxiety in UC patients**: 58% of patients with active UC had depressive symptoms and 50% had anxious symptoms. - **Microbiome characteristics**: The richness and diversity of the fecal microbiota in UC patients with depression/anxiety were lower, and certain bacteria (such as Lactobacillales, Sellimonas, Streptococcus and Enterococcus) increased, while other bacteria (such as Prevotella_9 and Lachnospira) decreased. - **Metabolome characteristics**: Most metabolites (such as glycocholic acid and glycochenodeoxycholic acid) in the serum of UC patients with depression/anxiety increased, while a few metabolites (such as 2' - deoxy - D - ribose and L - pyrrolidone acid) decreased. - **Proteome characteristics**: The immunoglobulin protein levels in the serum of UC patients with depression/anxiety were generally decreased. - **Animal experiment results**: Preventive administration of 2' - deoxy - D - ribose and L - pyrrolidone acid significantly reduced the depressive - like behaviors in colitis mice and alleviated the levels of inflammatory cytokines in their colon, blood and brain. ### Conclusion: This study, through multi - omics analysis, reveals the complex network of UC - related depression and anxiety, including specific gut microbiota, metabolites and proteins. These findings provide potential targets for clinical intervention in UC - related mental disorders.

Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics

Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients

Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients with Ulcerative Colitis in Clinical Remission

Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients

Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity

Altered Fecal Metabolites and Colonic Glycerophospholipids Were Associated With Abnormal Composition of Gut Microbiota in a Depression Model of Mice

Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis

Regulation of colonic neuropeptide Y expression by the gut microbiome in patients with ulcerative colitis and its association with anxiety- and depression-like behavior in mice

Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis

Gut Microbiota and Metabolite Changes in Patients With Ulcerative Colitis and Clostridioides difficile Infection

Metabolomics changes in brain-gut axis after unpredictable chronic mild stress

Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression

Gut Microbiota-Mediated Elevated Production of Secondary Bile Acids in Chronic Unpredictable Mild Stress

Immunoregulatory role of the gut microbiota in inflammatory depression

A pilot exploration of multi-omics research of gut microbiome in major depressive disorders

Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder

The Gut Microbiome Modulates the Changes in Liver Metabolism and in Inflammatory Processes in the Brain of Chronic Unpredictable Mild Stress Rats

An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients

Core Antibiotic Resistance Genes Mediate Gut Microbiota to Intervene in the Treatment of Major Depressive Disorder

Effects of chronic unpredictable mild stress on gut microbiota and fecal amino acid and short-chain fatty acid pathways in mice

Multi-cohort analysis of depression-associated gut bacteria sheds insight on bacterial biomarkers across populations